The EESI project consortium has been designed to represent a cross-section of European and international key actors in the field of HPC. The partnership has a deep and broad expertise in all the technological and strategic aspects related to HPC.
The consortium is composed of:
The School of Pharmacy at the University of Nottingham leads the UK in the training of future Pharmacists and in undertaking world changing research. Rated 1st in the UK Research Assessment Exercise for Pharmacy and in the top 2% of all university departments in any subject in the UK, we are recognised as a world leader for research in the design and use of drugs and medicines. Many of these activities involve significant HPC activity.
Dr Charlie Laughton is Associate Professor and Reader in Molecular Recognition. He works on development and application of HPC methods to the discovery and development of new drugs, particularly new anticancer agents. He was the founding chair of the Collaborative Computational Project for Biomolecular Simulation (CCPB).